Skip to main content
. 2018 Dec 27;11:143. doi: 10.1186/s13045-018-0685-2

Fig. 1.

Fig. 1

Dosing strategies for bosutinib therapy in CP-CML Abbreviations: AEs, adverse events; CP chronic-phase; CML chronic myeloid leukemia; TKI, tyrosine kinase inhibitor